Overactive bladder (OAB) is a common condition that significantly impacts the quality of life (QoL), well-being and daily functioning for both men and women. Among various treatments, peripheral tibial nerve stimulation (PTNS) emerges as an effective third-line treatment for OAB symptoms, with options for either a percutaneous approach (P-PTNS) or by transcutaneous delivery (T-PTNS). Recent studies have shown negligible differences between P-PTNS and T-PTNS efficacy in alleviating urinary urgency and frequency and QoL improvement and, overall no difference in efficacy over antimuscarinic regimens. The TENSI+ system offers a cutting-edge transcutaneous approach, allowing patients to self-administer treatment conveniently at home with electrical stimulation delivery through surface electrodes. It stands out for its ease of preparation, tolerability, and high levels of patient satisfaction. Prospective multicentric data highlights TENSI+ to be an effective and safe treatment for lower urinary tract symptoms with high treatment adherence at 3 months. This paper aims to familiarize readers with the TENSI+ system, current studies, device assembly, operation, and treatment recommendations.
The Canadian journal of urology. 2023 Dec [Epub]
Jean-Nicolas Cornu, Hashim Hashim, Frank Van Der Aa, Cosimo De Nunzio, Valentina Garcia Perez, Roseanne Ferreira, Dean S Elterman
Department of Urology, Charles Nicolle University Hospital, University of Rouen, Rouen, France., Bristol Urological Institute, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom., Department of Urology, University Hospitals Leuven, Catholic University Leuven, Leuven, Belgium., Department of Urology, Sapienza University of Rome, Rome, Italy., Department of Medicine, University of the Andes, Bogota, Colombia., Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.